Infinity Pharmaceuticals | INFI - Equity Capital And Reserves


Infinity Pharmaceuticals reported $-37.41M in Equity Capital and Reserves for its fiscal quarter ending in June of 2023.





Equity Capital And Reserves Change Date
AbbVie USD -6.66B 3.39B Mar/2026
Alterity Therapeutics Limited AUD 36.21M 18.58M Dec/2025
Amgen USD 9.19B 532M Mar/2026
AstraZeneca USD 47.33B 1.33B Mar/2026
Bristol-Myers Squibb USD 20.07B 1.6B Mar/2026
Cipla INR 329.19B 16.3B Sep/2025
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 102.73M 58.9M Dec/2025
CSL USD 18.66B 2.75B Dec/2025
Eisai JPY 889.64B 35.21B Dec/2025
Eli Lilly USD 31.2B 4.66B Mar/2026
Gilead Sciences USD 23.52B 897M Mar/2026
GlaxoSmithKline GBP 17.42B 1.05B Mar/2026
Grifols EUR 6.21B 133.12M Dec/2025
Incyte USD 5.62B 455.37M Mar/2026
Infinity Pharmaceuticals USD -37.41M 9.08M Jun/2023
Ionis Pharmaceuticals USD 491.41M 2.32M Mar/2026
J&J USD 81.19B 358M Mar/2026
Novartis USD 38.93B 7.2B Mar/2026
Pfizer USD 90.1B 3.63B Mar/2026
Plus Therapeutics USD 11.96M 7.96M Mar/2026
Roche Holding CHF 33.8B 758M Dec/2025
TG Therapeutics USD 583.13M 64.89M Mar/2026